Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8117317rdf:typepubmed:Citationlld:pubmed
pubmed-article:8117317lifeskim:mentionsumls-concept:C0003402lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0014912lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0014930lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0039286lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C0023775lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:8117317lifeskim:mentionsumls-concept:C2347946lld:lifeskim
pubmed-article:8117317pubmed:issue3lld:pubmed
pubmed-article:8117317pubmed:dateCreated1994-3-25lld:pubmed
pubmed-article:8117317pubmed:abstractTextThe pure antioestrogen ICI 164,384, and nafoxidine (structurally related to tamoxifen) were good inhibitors of iron ion-dependent lipid peroxidation. In rat liver microsomes incubated with Fe(III)-ascorbate the overall order of effectiveness of the compounds tested as inhibitors of lipid peroxidation was 4-hydroxytamoxifen > 17 beta-oestradiol > nafoxidine > or = tamoxifen > ICI 164,384. When the microsomes were incubated with Fe(III)-ADP/NADPH, a similar order of effectiveness was observed. In ox-brain phospholipid liposomes incubated with Fe(III)-ascorbate the order was 4-hydroxytamoxifen > 17 beta-oestradiol > ICI 164,384 > tamoxifen > or = nafoxidine. The antioxidant ability of ICI 164,384, a steroidal oestrogen antagonist, is compared to that of tamoxifen (a non-steroidal antioestrogen and partial oestrogen agonist) and 17 beta-oestradiol and is discussed in relation to its anticancer action.lld:pubmed
pubmed-article:8117317pubmed:languageenglld:pubmed
pubmed-article:8117317pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:citationSubsetIMlld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8117317pubmed:statusMEDLINElld:pubmed
pubmed-article:8117317pubmed:monthFeblld:pubmed
pubmed-article:8117317pubmed:issn0006-2952lld:pubmed
pubmed-article:8117317pubmed:authorpubmed-author:WisemanHHlld:pubmed
pubmed-article:8117317pubmed:issnTypePrintlld:pubmed
pubmed-article:8117317pubmed:day9lld:pubmed
pubmed-article:8117317pubmed:volume47lld:pubmed
pubmed-article:8117317pubmed:ownerNLMlld:pubmed
pubmed-article:8117317pubmed:authorsCompleteYlld:pubmed
pubmed-article:8117317pubmed:pagination493-8lld:pubmed
pubmed-article:8117317pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:meshHeadingpubmed-meshheading:8117317-...lld:pubmed
pubmed-article:8117317pubmed:year1994lld:pubmed
pubmed-article:8117317pubmed:articleTitleThe antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential.lld:pubmed
pubmed-article:8117317pubmed:affiliationPharmacology Group, King's College, University of London, U.K.lld:pubmed
pubmed-article:8117317pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8117317pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8117317pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8117317lld:pubmed